Chapter 16.5
Human Hereditary Porphyrias
Elisabeth Irene Minder,
Xiaoye Schneider-Yin,
Elisabeth Irene Minder
Search for more papers by this authorXiaoye Schneider-Yin
Search for more papers by this authorElisabeth Irene Minder,
Xiaoye Schneider-Yin,
Elisabeth Irene Minder
Search for more papers by this authorXiaoye Schneider-Yin
Search for more papers by this authorBook Editor(s):Juan Rodés MD,
Jean-Pierre Benhamou MD,
Andres T. Blei MD,
Jürg Reichen MD,
Mario Rizzetto MD,
Juan Rodés MD
Director General, Hospital Clinic; Professor of Medicine, University of Barcelona, Barcelona, Spain
Search for more papers by this authorJean-Pierre Benhamou MD
Professor of Hepatology, Université Denis Diderot Paris 7, Assistance Publique — Hôpitaux de Paris and Inserm U773, Service d'Hépatologie, Hôpital Beaujon, Clichy, France
Search for more papers by this authorAndres T. Blei MD
Professor of Medicine and Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
Search for more papers by this authorJürg Reichen MD
Professor of Medicine, University of Bern; Chief of Hepatology, University Hospital, Bern, Switzerland
Search for more papers by this authorMario Rizzetto MD
Professor of Gastroenterology, University of Turin, Turin, Italy
Search for more papers by this author
References
- Sandberg S Elder GH (2004) Diagnosing acute porphyrias. Clin Chem 50, 803–805.
- Anderson KE Bloomer JR Bonkovsky HL et al. (2005) Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med 142, 439–450.
- Liu YP Lien WC Fang CC (2005) ED presentation of acute porphyria. Am J Emerg Med 23, 164–167.
- Albers JW Fink JK (2004) Porphyric neuropathy. Muscle Nerve 30, 410–422.
- Hift RJ Meissner PN (2005) An analysis of 112 acute porphyric attacks in Cape Town, South Africa. Evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity. Medicine 84, 48–60.
- Bylesjo I Brekke OL Prytz J et al. (2004) Brain magnetic resonance imaging white-matter lesions and cerebrospinal fluid findings in patients with acute intermittent porphyria. Eur Neurol 51, 1–5.
- Bylesjö I Forsgren L Lithner F et al. (1996) Epidemiology and clinical characteristics of seizures in patients with acute intermittent porphyria. Epilepsia 37, 230–235.
- Reynolds NC (1982) Seizure management and hepatic porphyrias. Neurology 32, 1409–1410.
- Winkler AS Peters TJ Elwes RD (2005) Neuropsychiatric porphyria in patients with refractory epilepsy: report of three cases. J Neurol Neurosurg Psychiatr 76, 380–383.
- Pischik E Bulyanitsa A Kazakov V et al. (2004) Clinical features predictive of a poor prognosis in acute porphyria. J Neurol 251, 1538–1541.
- European Porphyria Initiative (2005) http://www.porphyria-europe.com/ (accessed June 2005).
- von und zu Fraunberg M Pischik E Udd L et al. (2005) Clinical and biochemical characteristics and genotype-phenotype correlation in 143 Finnish and Russian patients with acute intermittent porphyria. Medicine 84, 35–47.
- Mustajoki P Nordmann Y (1993) Early administration of heme arginate for acute porphyric attacks. Arch Intern Med 153, 2004–2008.
- Herrick AL McColl KE Moore MR et al. (1989) Controlled trial of haem arginate in acute hepatic porphyria. Lancet 1 (8650), 1295–1297.
- Bonkovsky HL Barnard GF (1998) Diagnosis of porphyric syndromes: a practical approach in the era of molecular biology. Semin Liver Dis 18, 57–66.
- Gross U Honcamp M Daume E et al. (1995) Hormonal oral contraceptives, urinary porphyrin excretion and porphyrias. Horm Metab Res 27, 379–383.
- Soonawalla ZF Orug T Badminton MN et al. (2004) Liver transplantation as a cure for acute intermittent porphyria. Lancet 363 (9410), 705–706.
- Stojeba N Meyer C Jeanpierre C et al. (2004) Recovery from variegate porphyria by liver transplantation. Liver Transpl 10, 935–938.
- Andersson C Floderus Y Wikberg A et al. (2000) The W198X and R173W mutations in the porphobilinogen deaminase gene in acute intermittent porphyria have higher clinical penetrance than R167W. Scand J Clin Lab Invest 60, 833–638.
- Schuurmans MM Schneider-Yin X Rufenacht UB et al. (2001) Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients. Mol Med 7, 535–542.
- De Siervi A Rosetti MV Parera VE et al. (1999) Acute intermittent porphyria: biochemical and clinical analysis in the Argentinean population. Clin Chim Acta 288, 63–71.
- Nordmann Y Puy H Da Silva V et al. (1997) Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France. J Intern Med 242, 213–217.
- Grandchamp B (1998) Acute intermittent porphyria. Semin Liver Dis 18, 17–24.
- Lindberg RLP Porcher C Grandchamp B et al. (1996) Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria. Nature Genet 12, 195–199.
- Jover R Hoffmann F Scheffler-Koch V et al. (2000) Limited heme synthesis in porphobilinogen deaminase-deficient mice impairs transcriptional activation of specific cytochrome P450 genes by phenobarbital. Eur J Biochem 267, 7128–7137.
- Solis C Martinez-Bermejo A Naidich T et al. (2004) Acute intermittent porphyria. Studies of the severe homozygous dominant disease provides insights into the neurologic attacks in acute porphyrias. Arch Neurol 61, 1764–1770.
- Lithner F Wetterberg L (1984) Hepatocellular carcinoma in patients with acute intermittent porphyria. Acta Med Scand 215, 271–274.
- Andant C Puy H Bogard C et al. (2000) Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. J Hepatol 32, 933–939.
- Holmgren M Andersson C (2005) Does screening for hepatocellular carcinoma benefit patients with acute intermittent porphyria? Abstract. Conference on Porphyrins and Porphyrias, Cape Town. http://www.porphyria-europe.com/02-for-healthcare/abstracts/abstractforms.asp/ (accessed June 2005).
- Human Gene Mutation Database (2005) http://www.hmgd.cf.ac.uk/ (accessed June 2005).
- Lee JS Anvret M (1991) Identification of the most common mutation within the porphobilinogen deaminase gene in Swedish patients with acute intermittent porphyria. Proc Natl Acad Sci USA 88, 10912–10915.
-
De Siervi A
Rosetti MV
Parera VE et al.
(1999)
Identification and characterization of hydroxymethylbilane synthase mutations causing acute intermittent porphyria: evidence for an ancestral founder of the common G111R mutation.
Am J Med Genet
86,
366–375.
10.1002/(SICI)1096-8628(19991008)86:4<366::AID-AJMG11>3.0.CO;2-# CAS PubMed Web of Science® Google Scholar
- Greene-Davis ST Neumann PE Mann OE et al. (1997) Detection of a R173W mutation in the porphobilinogen deaminase gene in the Nova Scotian ‘foreign Protestant’ population with acute intermittent porphyria: a founder effect. Clin Biochem 30, 607–612.
- Schneider-Yin X Hergersberg M Goldgar D et al. (2002) Ancestral founder of mutation W283X in the porphobilinogen deaminase gene among acute intermittent porphyria patients. Hum Hered 54, 69–81.
- Schneider-Yin X Hergersberg M Schuurmans MM et al. (2004) Mutation hotspots in the human porphobilinogen deaminase gene: recurrent mutations G111R and R173Q occurring at CpG motifs. J Inherit Metab Dis 27, 625–631.
- Minder EI (1993) Coproporphyrin isomers in acute-intermittent porphyria. Scand J Clin Lab Invest 53, 87–90.
- Grandchamp B Picat C Kauppinen R et al. (1989) Molecular analysis of acute intermittent porphyria in a Finnish family with normal erythrocyte porphobilinogen deaminase. Eur J Clin Invest 19, 415–418.
- Whatley SD Puy H Morgan RR et al. (1999) Variegata porphyria in western Europe: identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation. Am J Hum Genet 65, 984–994.
- Long C Smyth SJ Woolf J et al. (1993) Detection of latent variegate porphyria by fluorescence emission spectroscopy of plasma. Br J Dermatol 129, 9–13.
- Hift RJ Davidson BP Van der Hoft C et al. (2004) Plasma fluorescence scanning and fecal porphyrin analysis for the diagnosis of variegate porphyria: precise determination of sensitivity and specificity with the detection of protoporphyrinogen oxidase mutations as a standard. Clin Chem 50, 915–923.
- Meissner PN Dailey TA Hift RJ et al. (1996) A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria. Nature Genet 13, 95–97.
- McColl KE Moore MR Thompson GG et al. (1981) Abnormal haem biosynthesis in chronic alcoholics. Eur J Clin Invest 11, 461–468.
- Gouya L Puy H Robreau AM et al. (2004) Modulation of penetrance by the wild-type allele in dominantly inherited erythropoietic protoporphyria and acute hepatic porphyrias. Hum Genet 114, 256–262.
- Doss M von Tiepermann R Schneider J et al. (1979) New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation. Klin Wochenschr 57, 1123–1127.
- Granick JL Sassa S Granick S et al. (1973) Studies in lead poisoning. II. Correlation between the ratio of activated to inactivated delta-aminolevulinic acid dehydratase of whole blood and the blood lead level. Biochem Med 8, 149–159.
- Meerman L Verwer R Slooff MJ et al. (1994) Perioperative measures during liver transplantation for erythropoietic protoporphyria. Transplantation 57, 155–158.
- Mathews-Roth MM (1984) Treatment of erythropoietic protoporphyria with beta-carotene. Photodermatology 1, 318–321.
- Nishioka E Funasaka Y Bito T et al. (2003) Porphyria cutanea tarda with postmenopausal exacerbation: the possible role of menstruation as natural phlebotomy. J Am Acad Dermatol 49, 547–550.
- Kushner JP Edwards CQ Dadone MM et al. (1985) Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda. Gastroenterology 88, 1232–1238.
- Roberts AG Whatley SD Nicklin S et al. (1997) The frequency of hemochromatosis-associated alleles is increased in British patients with sporadic porphyria cutanea tarda. Hepatology 25, 159–161.
- Elder GH (1975) Differentiation of porphyria cutanea tarda symptomatica from other types of porphyria by measurement of iso-coproporphyrin in faeces. J Clin Pathol 28, 601–607.
- Bulaj ZJ Franklin MR Phillips JD et al. (2000) Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda. J Lab Clin Med 136, 482–488.
- Stölzel U Köstler E Schuppan D et al. (2003) Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda. Arch Dermatol 139, 309–313.
- Goerz G Krieg T Eichenauer MG (1976) Accident in treatment of porphyria cutanea tarda by chloroquine (Resochin). Arch Dermatol Res 255, 169–176.
- Fernandez I Castello G de Salamanca RE et al. (2003) Porphyria cutanea tarda as a predictor of poor response to interferon alfa therapy in chronic hepatitis C. Scand J Gastroenterol 38, 314–319.
- Deybach JC de Verneuil H Phung N et al. (1981) Congenital erythropoietic porphyria (Gunther's disease): enzymatic studies on two cases of late onset. J Lab Clin Med 97, 551–558.
- Tonz O Vogt J Filippini L et al. (1975) Severe light dermatosis following photo therapy in a newborn infant with congenital erythropoietic uroporphyria. Helv Paediatr Acta 30, 47–56.
- Shaw PH Mancini AJ McConnell JP et al. (2001) Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature. Bone Marrow Transplant 27, 101–105.
- Pimstone NR Gandhi SN Mukerji SK (1987) Therapeutic efficacy of oral charcoal in congenital erythropoietic porphyria. N Engl J Med 316, 390–393.
- Minder EI Schneider-Yin X Moll F (1994) Lack of effect of oral charcoal in congenital erythropoietic porphyria. N Engl J Med 330, 1092–1094.
- Guarini L Piomelli S (1994) Hydroxyurea in congenital erythropoietic porphyria. N Engl J Med 330, 1091–1092.
- Warner CA Yoo HW Roberts AG et al. (1992) Congenital erythropoietic porphyria: identification and expression of exonic mutations in the uroporphyrinogen III synthase gene. J Clin Invest 89, 693–700.
- Ged C Megarbane H Chouery E et al. (2004) Congenital erythropoietic porphyria: report of a novel mutation with absence of clinical manifestation in a homozygous mutant sibling. J Invest Dermatol 123, 589–591.
- Bewley AP Keefe M White J (1998) Erythropoietic protoporphyria improving during pregnancy. Br J Dermatol 139, 145–147.
- Bloomer JR Phillips MJ Davidson DL et al. (1975) Hepatic disease in erythropoietic protoporphyria. Am J Med 58, 869–882.
-
Gordeuk VR
Brittenham CM
Hawkins CW et al.
(1986)
Iron therapy for hepatic dysfunction in erythropoietic protoporphyria.
Ann Intern Med
205,
27–31.
10.7326/0003-4819-105-1-27 Google Scholar
- Went LN Klasen EC (1984) Genetic aspects of erythropoietic protoporphyria. Ann Hum Genet 48, 105–117.
- Gouya L Deybach JC Lamoril J et al. (1996) Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. Am J Hum Genet 58, 292–299.
- Gouya L Puy H Robreau AM et al. (2002) The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FEC. Nature Genet 30, 27–82 30.
- Whatley SD Mason NG Khan M et al. (2004) Autosomal recessive erythropoietic protoporphyria in the United Kingdom: prevalence and relationship to liver disease. J Med Genet 41, e105.
- Sarkany RP Alexander GJ Cox TM (1994) Recessive inheritance of erythropoietic protoporphyria with liver failure. Lancet 344, 958–959.
- Minder EI Gouya L Schneider-Yin X et al. (2002) A genotype-pheno-type correlation between null-allele mutations in the ferrochelatase gene and liver complication in patients with erythropoietic protoporphyria. Cell Mol Biol (Noisy-le-grand) 48, 91–96.
- Bonkovsky HL Schned AR (1986) Fatal liver failure in protoporphyria. Synergism between ethanol excess and the genetic defect. Gastroenterology 90, 191–201.
- Bloomer JR Rank JM Payne WD et al. (1996) Follow-up after liver transplantation for protoporphyric liver disease. Liver Transpl Surg 2 (4), 269–275.
- Hift RJ Meissner PN Todd G et al. (1993) Homozygous variegate porphyria: an evolving clinical syndrome. Postgrad Med J 69, 781–786.
- Roberts AG Puy H Dailey TA et al. (1998) Molecular characterization of homozygous variegate porphyria. Hum Mol Genet 7 (11), 1921–1925.
- Nordmann Y Grandchamp B de Verneuil H et al. (1983) Har-deroporphyria: a variant hereditary coproporphyria. J Clin Invest 72, 1139–1149.
- Lamoril J Puy H Whatley SD et al. (2001) Characterization of mutations in the CPO gene in British patients demonstrates absence of genotype-phenotype correlation and identifies relationship between hereditary coproporphyria and harderoporphyria. Am J Hum Genet 68, 1130–1138.
- de Verneuil H Grandchamp B Romeo P et al. (1986) Molecular analysis of uroporphyrinogen decarboxylase deficiency in a family with two cases of hepatoerythropoietic porphyri. J Clin Invest 77, 431–435.
